U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting
U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
Elizabeth Cook talks with Dr. Desi Kotis, chief pharmacy executive at UCSF Health. (10-14-21)
- KIVI - Boise Scripps
There's been a lot of conversation surrounding natural immunity for COVID-19 with some insisting they might not need a vaccine because they've already contracted the virus.
The FDA Advisory Committee is meeting on Thursday to consider Moderna’s request for emergency use authorization for its booster shot. https://www.abcactionnews.com/news/coronavirus/fda-to-consider-moderna-covid-19-booster-shots-at-thursdays-advisory-committee-meeting
U.S. health advisors are now endorsing booster shots for many Americans who received the Moderna vaccine.
- ABC News Videos
Plus, major supply chain issues are threatening holiday shopping, and a young woman from Texas had to travel out of state to get an abortion.
- WCVB - Boston
"We could start seeing children under the age of 12 start getting vaccinated in November," said Dr. Rick Malley of Boston Children's Hospital.
- CBS News Videos
An FDA advisory committee endorsed Moderna's COVID-19 booster shot for people 65 and older and adults who are high-risk. Mireya Villarreal shares the latest.
- WTVF - Nashville Scripps
On today's MorningLine, we are joined by veterinarian Allison Fields. We'll take your questions and comments regarding your pets.
- Fox News
A U.S. Food and Drug Administration (FDA) advisory panel on Thursday endorsed emergency authorization for Moderna’s half-dose COVID-19 vaccine booster shot when administered at least six months following the two-dose series among people ages 65 and older and those ages 18-64 at high risk of occupational exposure and severe COVID-19.
By Sam Boughedda
- KTRK – Houston
The suspect is accused of distributing the certifications over the past seven years, using a real medical company's name to validate the bogus cards.
An FDA panel voted "yes" on recommending a third dose of the Moderna vaccine. Dr. Mallika Marshall explains what comes next in the process.
On the same day an FDA advisory committee recommended Moderna booster shots for vulnerable populations, a new clinic opened in Lowell. WBZ-TV's Christina Hager reports.
- WESH - Orlando Videos
Video shows fight between suspect and trooper that led to 6-hour manhunt
A New Study Makes the Case for Mixing and Matching the Pfizer-BioNTech, Moderna and J&J Vaccine Doses
The first large study of mixing and matching COVID-19 vaccine doses reveals encouraging news
- Best Life
Health experts and officials have battled over the idea of authorizing booster vaccine doses, as data has shown that vaccine protection against infection has waned over the last few months, thoguh most people remain heavily protected against severe COVID. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) voted in late September to authorize an additional dose of the Pfizer shot for certain high-risk groups who had gotten their second dose at lea
- CBS News Videos
Many Americans who received a Moderna COVID-19 vaccine could soon have access to a booster shot, after an FDA advisory panel unanimously endorsed a third dose. The panel will consider if a booster shot of the Johnson & Johnson vaccine is needed for those who received the single-dose vaccine. Weijia Jiang has the latest.
- Business Insider
CDC data confirms J&J is the worst-performing COVID-19 vaccine in the US - but being unvaccinated is far more dangerous
The CDC has released data breaking down COVID-19 cases and deaths by vaccination status, as well as vaccine brand.
Advisory committee supports authorizing a third, smaller dose of Covid vaccine for people aged 18 to 64 at high risk of severe disease, or whose work puts them at higher risk.